Stocks · Healthcare · Medical - Pharmaceuticals

Stablecoin Development Corp. SDEV

$7.48 +104.37% Close, Oct 2, 2026 · AMEX · Market cap $377.4M

Next earnings report: Nov 5, 2026

Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.

Three things to know

  1. The diluted share count rose 2568.3% in a year.
  2. The company holds net cash of $7.0M (cash above total debt).

PromtFinance scores

Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.

Growth—Not enough data

How fast revenue, earnings and cash flow are growing.

Quality23Very weak

Returns on capital, margins, earnings quality and balance-sheet strength.

  • Return on invested capitalTop 38%
  • Gross marginTop 7%
  • Operating marginBottom 27%
  • Cash conversion (OCF / net income)Bottom 7%
  • Accruals (lower is better)Bottom 1%
  • Interest coverBottom 21%
Value33Weak

How cheap the shares are relative to earnings, cash flow and their own history.

  • Earnings yieldBottom 16%
  • Free-cash-flow yieldTop 46%
  • EBITDA / enterprise valueTop 42%
  • Sales / enterprise valueBottom 9%
Momentum—Not enough data

Strength and persistence of the price trend, including versus the S&P 500.

  • 6-month returnTop 1%
Revisions96Exceptional

Earnings surprises and analyst sentiment (estimate-revision history is being collected).

  • Average EPS surprise, last 4 quartersTop 16%
  • Consecutive EPS beatsTop 35%
Stability29Very weak

Low volatility, shallow drawdowns, low market sensitivity and modest leverage.

  • Volatility, 60 days (lower is better)Bottom 1%
  • Maximum drawdown, 3 yearsTop 31%

Fundamental momentum

MeasureNow (TTM)Year / quarter beforeSector rank
Gross margin99.0%—Top 7%
Operating margin-141.1%—Bottom 27%
Net margin10354.3%——
Free-cash-flow margin-254.5%——
Return on invested capital-5.2%—Top 38%

Quality of earnings and balance sheet

Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
-0.02×
Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
388.4%
Stock-based compensation / revenueA cost to shareholders through dilution.
0.0%
Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
Net cash
Interest cover (operating income / interest)How many times operating profit covers interest.
-29.3×

Shareholder returns

Dividend yield (dividends paid, TTM)
1.28%
Net buyback yield (TTM)
-13.78%
Shareholder yield
-12.50%
Share count change, 1 year
+2568.3%
Share count change, 3-year CAGR
+1094.9%

Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.

Based on the four quarters through Jun 30, 2026 (filed Jun 30, 2026).

Earnings and expectations

Earnings momentum

Consecutive EPS beats
2
Beats in the last 8 reports
2 of 8
Average EPS surprise, last 4
+36.3%
Average 2-day reaction, last 8
+2.2%
Positive 20 days after report
0 of 2

How the stock reacted to recent reports

Report dateEPS surprise2 days5 days20 days60 days
Jul 30, 2026+101.8%+4.4%-8.8%-14.2%—
May 15, 2026+110.0%+0.0%-9.8%-38.4%-36.6%

Returns from the close before each report. Past reactions do not determine future ones.

Earnings history

Report dateEPSEstimateSurpriseRevenue
Jul 30, 2026$0.01-$0.55+101.8%$2.2M
May 15, 2026$0.10-$1.00+110.0%$2.5M
Nov 7, 2025-$1.15-$1.05-9.5%$521,000
Aug 14, 2025-$1.65-$1.05-57.1%—
May 15, 2025-$3.33-$1.20-177.5%—
Apr 2, 2025-$23.45-$1.20-1854.2%$2.3M
Nov 7, 2024-$3.00-$1.53-96.7%$2.4M
Aug 13, 2024-$6.85-$6.13-11.8%$2.4M

Valuation in context

MultipleNow5-year median5-year percentileSector rank (cheapness)
EV / Sales79.33×——Bottom 9%
Free-cash-flow yield-3.15%——Top 46%
Earnings yield-48.93%——Bottom 16%

Technical state

Trend checklist

  • ✓ Price above 20-day average
  • ✓ Price above 50-day average
  • ✓ MACD histogram positive

Trend quality

Days above the 50-day average
9
50-day average slope (20 days)
+16.6%
Distance from 50-day average
+480.3%
RSI (14)
89.3
Relative volume
8.21×

Risk and drawdowns

Volatility, 60 days (annualized)
248.8%
Current drawdown from 1-year high
+0.0%
Maximum drawdown, 3 years
-57.1%

Largest declines in the past six years

From peakTo lowDeclineLengthRecovery
Apr 2, 2026Sep 16, 2026-57.1%114 days9 days (Sep 29, 2026)
Sep 29, 2026Sep 30, 2026-20.8%1 days1 days (Oct 1, 2026)
Mar 16, 2026Mar 20, 2026-20.0%4 days2 days (Mar 24, 2026)
Mar 26, 2026Mar 30, 2026-11.8%2 days2 days (Apr 1, 2026)

Declines of 10% or more from a closing high, measured on daily closes.

Financial statements

Market cap
$377.4M
EPS, diluted (TTM)
-$3.66
Revenue (TTM)
$4.7M
FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue$10.2M$14.4M$10.5M$0$0
Gross profit$6.5M$7.8M$6.1M-$341,000-$140,000
Operating income-$8.9M-$7.7M-$4.1M-$7.4M-$7.6M
Net income-$5.8M-$10.6M-$6.1M-$7.2M-$642.0M
EPS (diluted)-$920.46-$1,767.93-$550.08-$12.68-$110.31
Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Revenue$0$0$0$0$521,000-$521,000$2.5M$2.2M
Net income-$1.2M-$1.2M-$3.5M-$1.9M-$1.3M-$26.6M$552.4M-$41.1M
EPS (diluted)-$9.60-$1.24-$3.33-$1.65-$1.10-$4.57$3.33-$1.32
FY 2021FY 2022FY 2023FY 2024FY 2025
Operating cash flow-$9.2M-$6.7M-$4.3M-$7.5M-$8.4M
Capital expenditure-$52,000-$112,000-$19,000$0$0
Free cash flow-$9.2M-$6.8M-$4.3M-$7.5M-$8.4M
Dividends paid$0$0$0$0-$4.8M
Net share buybacks$16.7M$4.7M$565,000$3.1M$10.5M

Cash outflows are shown as negative numbers.

Cash and short-term investments
$7.0M
Total assets
$127.5M
Total liabilities
$270,000
Total debt
$0
Net debt
-$7.0M
Shareholders’ equity
$127.2M

As of Jun 30, 2026 (filed Jun 30, 2026).

Dividends

Ex-dateAmountPaid
Sep 30, 2025$4.00—

Short interest

Shares sold short
1,212,152
Days to cover
4.40
Change vs previous report
+2.9%

FINRA short interest, settlement date Sep 15, 2026.

Stock splits

Feb 23, 2026
1-for-5
May 31, 2024
1-for-35
Nov 16, 2022
1-for-35
Dec 21, 2015
1-for-25